This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk06: Good morning and welcome to the Sensing Technologies Corporation 2022 Third Quarter Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touchtone phone. To withdraw your question, please press star then two. Please note, this event is being recorded. I would now like to turn the conference over to Mr. Steve Rolfs. Please go ahead, sir.
spk00: Good morning. Welcome to Censium's third quarter earnings call. I'm Steve Rolfs, Senior Vice President and Chief Financial Officer of Censium Technologies Corporation. I am joined today by Paul Manning, Censium's Chairman, President, and Chief Executive Officer. Earlier today, we released our 2022 third quarter financial results. A copy of the release and our investor presentation is available on our website at sentient.com. During our call today, we will be explaining the differences between our GAAP results and our adjusted results. We did not make any adjustments to our GAAP results for 2022. The adjusted results for 2021 remove the impact of the divestiture-related costs, the results of the operations divested, and the impact of the costs and income related to our operational improvement plan. We believe the removal of these items provides investors with additional information to evaluate the company's performance and improves the comparability of results between reporting periods. This also reflects how management reviews and evaluates the company's operations and performance. These non-GAAP financial results should not be considered in isolation from, or as a substitute for, financial information calculated in accordance with GAAP. A reconciliation of non-GAAP financial measures to the most directly comparable GAAP financial measures is available in our press release. We encourage investors to review these reconciliations in connection with the comments we make today. I would also like to remind everyone that comments made during this call, including responses to your questions, may include forward-looking statements. Our actual results may differ materially from those that may be expressed or implied due to a wide range of factors, including those set forth in our SEC filings. We urge you to read Sentient's previous SEC filings, including our and our first quarter and second quarter 10Q and our forthcoming 10Q for a description of additional factors that could potentially impact our financial results. Please bear these factors in mind when you analyze our comments today.
spk02: Thanks, Steve. Good morning and good afternoon. Earlier today, we reported our third quarter results. We had another strong quarter of revenue and operating profit growth in each group. Nearly every business in the company reported strong revenue and operating profit growth. Our year-to-date performance has been outstanding and follows our strong results from 2021 and 2020. In early October, we completed the acquisition of Endemics, a natural color and extract company based in Turkey. This acquisition strengthens our extensive natural color portfolio and improves our vertical integration for critical raw materials. We continue to look at other acquisition opportunities that support our strategic initiatives within our core product lines. Our focus on sales execution, technical support, and product delivery continue to fuel our growth. We have proven to be a reliable supplier to our customers, and we continue to win new projects across each group. Our focus on on-time customer delivery, technical support, and a robust product portfolio has positioned us nicely for future growth. As discussed throughout this year, we continue to experience increases in our input costs, including raw materials, transportation, energy, and labor. We are addressing these rising input costs with disciplined pricing actions, and we continue to maintain a higher inventory position to address ongoing supply chain challenges. While we have seen some signs of relief in select raw materials, Most categories remain elevated, and we saw continued increases in costs this quarter across the company. Despite the current global economic environment, I continue to expect to generate solid growth across the company. Sancient is a recession-resistant business that I believe can weather the current global economic challenges. Therefore, we are confirming our growth expectations for 2022. We're also confident in our 2023 prospects. Overall, we believe the year will finish with a more normal mid-single-digit revenue growth and mid-to-high single-digit operating profit growth. I will now discuss the group results. Color Group had another excellent quarter. The group delivered 15% adjusted local currency revenue growth and 11% adjusted local currency operating profit growth. Operating profit margin in the third quarter was 18.6%. and was impacted by our continuing increases in raw materials and other costs. Food and pharmaceutical colors and personal care both delivered strong third quarter results. The group's revenue increase was driven by a high single digit price increase and mid single digit volume growth. The food and pharmaceutical business delivered double digit adjusted local currency revenue and double digit adjusted local currency operating profit growth in the quarter. This year, the business has generated a high level of new sales wins stemming from its innovative natural color portfolio and its focus on customer service. Our recent acquisition of Endemics will strengthen our supply chain and support the strong project wins we are seeing in natural colors. The integration of Endemics has begun and I expect this integration will continue throughout 2023. The personal care business delivered high single digit local currency revenue and double digit local currency operating profit growth in the third quarter. Like the food and pharmaceutical business, the personal care business benefited from an innovative product portfolio, strong customer service, and product line diversification. These factors provide the foundation for growth going forward. Color Group is having an exceptional year. The group is on track to deliver double-digit revenue growth and double-digit operating profit growth and an operating margin close to 20% in 2022. Over the long term, I expect the color group to deliver mid-single-digit revenue growth and an operating margin of 20%. The flavors and extracts group delivered 7% adjusted local currency revenue growth and 6% adjusted local currency operating profit growth. The group's operating profit margin in the third quarter was 14.1% and is up 10 basis points compared to the prior year. The year-to-date operating profit margin is 15%, up 120 basis points compared to the prior year. Revenue growth in the group benefited from a 12% pricing increase in the quarter. As we have mentioned during our last few calls, the natural ingredients business has faced a volume headwind throughout 2022 as a result of onion availability. I had initially anticipated a return to normalcy in this product line in Q3, but that did not fully materialize. We are now better positioned on our supply of the product, and I expect volumes to improve in the future. In natural ingredients, we continue to see increasing costs as a result of the inflationary environment for labor, energy, land, water, fertilizer, and other grower costs, as well as the ongoing drought in California. We will need to manage these input costs with additional pricing actions. In the rest of the flavors and extract group, revenue growth and operating profit growth was up double digits, primarily driven by pricing and modest volume growth. I expect the flavors and extracts group to deliver high single-digit revenue growth and double-digit operating profit growth for the year. Over the long term, I expect the Flavors and Extract Group to deliver mid-single-digit revenue growth, and I expect operating profit margin to improve 50 to 100 basis points annually for the next few years. The Asia-Pacific Group delivered 14% adjusted local currency revenue growth and 16% adjusted local currency operating profit growth. Operating margin in the third quarter was 19.7%. The group had solid revenue growth in almost all regions. Revenue growth was almost equally split between pricing and volume. The group is on track to deliver double-digit revenue growth and double-digit operating profit growth for the year. Over the long term, I continue to expect the group to deliver mid-single-digit revenue growth at our current margins. This year has been an excellent year for Censian. Our focus on sales execution and product delivery and our robust product offerings are the foundation for the growth we have achieved. Clearly, we have seen outsized growth in 2022, which we expect to moderate beginning in the fourth quarter and continuing into 2023. Overall, we are well on track to meet our full year guidance for 2022, and I remain optimistic about the year and the future of our business. Steve will now provide you with additional details on the third quarter results.
spk00: thank you Paul sentient third quarter gap diluted earnings per share was 85 cents as I mentioned in our opening remarks we do not have any adjustments to our gap results for the third quarter of 2022 last year's third quarter gap results included divestiture and operational improvement plan costs which decreased last year's third quarter results by approximately four cents per share in addition a Our GAAP earnings per share in the third quarter of 2021 included the operations of the divested product line, which were not material to diluted earnings per share. Our adjusted EPS in the third quarter of 2021 was 85 cents. Excluding these items in our 2021 results, our consolidated adjusted revenue in the third quarter of 2022 grew by 9.9% in local currency, to $361.1 million. Our adjusted local currency EBITDA was up 7.8% for the quarter, and our adjusted local currency EPS was up 7.1% for the quarter. Foreign currency exchange rates decreased adjusted earnings per share by approximately $0.06 in the third quarter. As we have stated throughout the year, we are making strategic investments in our inventory position, which is the main reason for our lower cash flow from operations this year. We continue to invest in inventory to support the high demand we are experiencing and to ensure we have appropriate safety stock positions as supply chain and energy challenges continue. We believe future inventory increases will be modest. Capital expenditures were $19.2 million for the third quarter. We continue to expect our capital expenditures to be near $90 million this year. We are prioritizing return on investment capital projects, and we hope to spend around $90 million next year. Our debt to adjusted EBITDA is 2.0. Our balance sheet remains well positioned to support our capital expenditures, sensible M&A, and our longstanding dividend. Regarding our 2022 guidance, we are maintaining our guidance that reported gap EPS will increase at a high teen growth rate compared to our 2021 reported gap EPS of $2.81. We do not anticipate any material divestiture-related costs or operational improvement plan costs in 2022. We expect to see additional cost increases in the fourth quarter and beyond. We also expect our interest expense to continue to increase in the fourth quarter compared to our third quarter interest expense of $3.7 million. We are maintaining our 2022 adjusted EBITDA and EPS guidance, which both call for high single- to double-digit growth in local currency. On an adjusted basis, we are also maintaining our revenue guidance to be up high single digits in local currency compared to our 2021 adjusted revenue. Based on current exchange rates, we expect currency to be a headwind of approximately 20 cents for the full year of 2022 for our GAAP-reported results. Thank you for participating in the call today. We will now open the call for questions.
spk06: Thank you. We will now begin the question-and-answer session. To ask a question, you may press star, then 1 on your touch-tone thumb. To withdraw your question, please press star, then 2. At this time, we will pause momentarily to assemble our roster. And the first question will be from Gansham Punjabi from Baird. Please go ahead.
spk04: Thank you. Hey, guys. Good morning. Good morning. Morning. Morning. I guess, you know, first off, Paul, maybe kind of building on your comments on volume moderation, 4Q onwards. I mean, clearly comparisons are more difficult for you, et cetera. But just how are you sort of thinking about, you know, at this point, volume outlook for 2023 in particular as you kind of run through the various segments?
spk02: Yeah, so I think in 2023, we feel like 5% mid-single-digit or so revenue, mid-to-high single operating profit growth is the good, sustainable, long-term expectation that investors and others should have for our groups. Now, what the composition of that may be and what is the timing of that, that's really getting at the nature of your question, right? So the long term, we feel very good about that type of growth model. As you look at 2023, it's anybody's guess when inflation stops and therefore pricing increases that we have to give moderate prices. So you could very well have a situation where we continue to price in the front half of the year and don't have to, and perhaps even have the ability to back off some pricing in the back half of the year. So trying to predict that at any one 90-day period is going to be particularly tricky. So I think that's why, as we think about the growth model, it may be up, it may be down on those averages on any given quarter. But I think we feel very good about that formula and the relationship between revenue and profit for 2023 and beyond that. But, you know, we continue to take pricing as we need to, depending on the business and depending on the market. But pricing, you know, you have to be, as you know, you have to be very, very sensitive. We're not here to throw as much pricing as we possibly can at our customers. You have to work with your customers, and you have to make sure you're not making their products uncompetitive. So this is not always an easy thing to do, and timing is very, very important, and the messaging is important. But I think we've done a fairly good job balancing the interests of our customers and then obviously the inflation that we feel. So net-net, mid-single, mid-to-high single on OP, mid-single on revenue for each of the groups in 23 is a pretty good number to write down and I think model out.
spk04: Okay, that's very helpful. And then just as a follow-up to that, you know, just in context of your customers obviously absorbing significant inflation across their various cost baskets on the ingredient side, how does that kind of fit in with your wheelhouse in terms of new product activity and maybe customers looking to substitute ingredients, you know, to kind of moderate the cost impact?
spk02: Yeah, that's a great question because the ultimate question here is how much new product activity do customers – so actually let me start that over. They have resources. Those resources can be strongly utilized for new products. Those resources can be strongly utilized for cost takeouts. So obviously that will vary significantly depending on the customer, depending on the region and the product line. There will be some customers who literally, I think, put the vast majority of their technical resources, shift them from new product launches to more of a cost takeout because it's an imminent problem in a number of businesses and product lines around the world. But in others, I think they'll continue a very robust pace. If I were to just kind of give you some overall measurements of the market, I mentioned on the last call for the first six months of 2022, new product launches for food and non-food in the U.S. and European markets by our sources were down double digits, which is to say launch activity in 23 versus 22 was down approximately 10% overall in those markets. Now, that moderated somewhat in Q3. From our databases, new product launches declined about 3% in Q3. So there is variance depending on the type of customer. Obviously, some of it was a little bit bigger, some a little bit smaller. But that would suggest that new launches will continue. And so part of what it emboldens me to say we can achieve these results moving into 23 and beyond is because there is still launch activity. Maybe it's line extensions over new-to-the-world products, but there's launch activity. If you're a good supplier, you're a reliable supplier, you're responsive, you can continue to capitalize on that dynamic for sure, even in a market in 23. We've obviously been doing that in 22 and 21 and then as well in 20. So I think continuing that approach and that expectation, I think we can continue to be successful.
spk04: Okay, just one final one, if I could, on the raw material side. What was 3Q inflation on a sequential basis relative to 2Q, and what's your initial guess on where you think 4Q will come in?
spk02: So it looks like on the year-to-date, we're looking at input costs. Overall, a little bit variance by the groups, but I would say it's about overall approaching 9% to 10% for the full year. As you look at Q3, it was right around that range, a little bit less worse in Asia than it was in, say, the Americas and in Europe. But think high single-digit inflation is a pretty good estimate. Decomposition will vary by group. whether it's raw material in some markets, labor and other transportation. We mentioned in the agricultural side, we have a lot of those input costs around fertilizer and water, which has a strong impact on the S&I business. But, you know, that also feeds into things that we do on extracts. That feeds into natural colors. But I think if you want to model that out kind of high single and it continued in Q3, I think specifically in Q2 is about 8%, and it looks like Q3 is about 8% or 9%. Perfect. Thank you so much. Okay. Thank you.
spk06: And our next question is from Heidi Vesternin from B&P Paribas. Please go ahead.
spk05: Good morning. Good morning, Heidi. I wanted to clarify what you said about flavors and extracts, please. So you talked about the volume supply issue and SNI. So could you maybe talk about volume and price by segment within flavor and extract? I'm wondering if the non-SNI part of the business had volume growth or not. Perhaps you could clarify that point, please. Thanks.
spk02: Sure. So just for everybody's benefit, as you look at what we call the flavors and extracts group, About one-third of that revenue is S&I. This is the onion, garlic, what I also call the agricultural business. About two-thirds of that flavors and extracts group is what folks would describe as traditional flavors, extracts, and ingredients. So volume decline is effectively isolated to S&I. We had modest volume growth. In the two-thirds of the flavors and extracts group related to flavor extracts and ingredients, we had modest growth in Q3, about 5% volume growth year-to-date. So the declines have been effectively isolated to that particular segment of the flavors and extracts group because you'll know that we also had very good volume growth in color and in Asia, both 5% to 6% volume growth. And these are in markets that are declining. And so I think that's a very noteworthy outcome for the company, obviously, X, S, and I. Thank you for that.
spk05: That's very clear. Next, I wondered if you could talk about the trends you're seeing by region in each business piece. Some companies have talked about destocking in certain areas, including North America. Some are cautious about the UK market. So what are you currently seeing in flavors and colors, please?
spk02: Yeah, and you're right to ask that on a regional basis because it does vary. And so just to make sure I'm calibrated here, when I'm talking destocking, I'm talking sentience customers potentially destocking. I'll tell you, compared to 2021, sure, there is destocking. Compared to 2019, kind of at the start of the pandemic, is there destocking? I don't know. I haven't really measured it that far back, but certainly on a year-over-year, there would be what I think most folks would describe as destocking underway, pretty much in most of the markets, most of the regions. And so our response to that, though, is they may be destocking some of our products, because our service levels have been quite good. So we're seeing a strong connection with our customers' destocking efforts. It's very much related to the reliability of their supply chain. So in other words, if they feel very comfortable that the flavors will continue to come and will come at a reasonable lead time and a predictable on-time delivery and a reliable on-time delivery, they're more apt to take those moves to destock particular raw materials, for example. So those, to me, are the real biggest factor. But the answer to your question, sure, there is absolutely destocking among our customers. But I think we've still obviously been very successful growing, winning, growing volume in the vast majority of the company and generating new wins, even with that somewhat of a headwind.
spk05: So are there any specific regions you would call out, or is it more on a global basis that you're seeing this?
spk02: You know, none really stand out to me that I fret over in any particular way. I think it's probably, you know, we may see a little bit more destocking in Europe than, say, the Americas. We're seeing less of this impact in the Asia-Pacific region. But, yeah, up until now, it's not really been a major concern for us. You know, as we look at our own inventory position, it's obviously elevated. But our intention there, it's intended, right? We want to and we have built stock on finished goods in some cases. raw materials on others because if you have it and you're reliable, you win business and you win more business. And so I accept the cash flow ramifications of that in the interest of generating the new wins and continuing to maintain customers' confidence in us. So, you know, there are some folks have asked, well, are you worried about shelf life? Well, not so much you know most of our products have a long enough shelf life that we can manage that process reasonably well that's not to say that these things last for thousands of years but certainly when you look at some of the personal care ingredients some of our colors these these have shelf lives that are are i'm not worried about obsolescence by any means the thing you really have to manage in a situation like this is that in the world where demand is kind of declining in some categories And as we referenced, you know, we're not going to remain a 15% revenue growth operation here for the long term. You know, I believe we will moderate back to the sort of the mid-single-digit growth rate. So managing that process, because you don't want to be stuck with a bunch of inventory, and then you have a bunch of underutilized plants, and then I don't need to get into accounting nonsense on that one, but you get the idea. there can be profit impacts from that. So I look more at inventory utilization of our plants rather than inventory obsolescence. But in the broader scheme of things, yeah, I think that destocking is certainly underway versus 21 and may very well continue. We expect it to continue into 2022. But again, a lot of that's tied to the reliability of the supply chain.
spk05: Thanks for that. And then there's another question, colors. So we saw that top line was extremely strong. Why wasn't there more operating leverage in colors? You talked about inflation, but did you basically see a bigger step up in inflation and are you seeing prices lagging or is there any other effects we should be thinking about?
spk02: I would say it's cost. I don't think there's any major change in our portfolio, the mix of products. In fact, I think the mix of products has been quite good, but it's cost. You can go out with a pricing increase and then two weeks later, you're like, oh gosh, I got another one. And so you can't keep going to customers every two weeks. And so you have to be very thoughtful about that. But in the very beginning of all this, we got well ahead of of the pricing situation. I think you noted that a couple of calls ago. So I think you saw this outsized relationship between revenue and profit, but now it's cost catch up and you may be on multiple rounds with customers trying to get the clarity of what's next, trying to find the right timing is certainly very, very important. So all things considered, I'm very happy with very strong revenue. We still have very good profit growth Most companies that I look at nowadays, they might have nice revenue growth, but they're declining profit. They have declining volumes. That's not a good recipe. I feel really good that Slick Colors has got, they're up 15%, 11% on profit. Yeah, okay, in a normal year, I'd be like, well, why aren't we getting more leverage? But it's anything but a normal year. And so I'm sitting here feeling really good about 15 and 11 with 6% volume growth. But I think, you know, as things get back to normal, sure. You will see more operating leverage as the inflationary environment sort of moderates. But yeah, I think we should all feel really good that Sentient's covering their costs, generating volume, generating new wins. It's not exactly how you draw it up from an operating leverage standpoint, but I think the alternatives these days are pretty dire in a lot of other places.
spk05: That's right. Thank you for that. I'll get back in the queue.
spk02: Okay. Thanks, Heidi.
spk06: The next question comes from Mitra Ramgopal from Sudoti. Please go ahead.
spk01: Yes. Good morning. Thanks for taking the questions. Hi, Mitra. Hi. On the last question there and the comments, a lot of companies seeing revenue growth, but margin deterioration certainly an issue. And I think you feel comfortable as you look out the next year, even if we were to have a recession, that you should still be able to go not just the top line, but the bottom line. So I'm just curious, in terms of what's separating you versus a lot of companies reporting headwinds, whether it's on raw materials, supply chain, labor costs, et cetera. You've obviously done a great job navigating that so far, and just curious as you look out to 23 if any of those headwinds apply.
spk02: Well, I can't necessarily speak to what other folks are doing, but I'll tell you what we're doing. We focus on running this business, sales execution, customer service, customers come first, And we don't really engage in other sorts of nonsense, Mitra. We're kind of a no excuse style operation. And people like that because when you win, people get very, very excited. And so some of it is just that philosophy. But the practical matter of keeping customers first, really emphasizing new wins, and even when there may be slowdowns, we don't build in excuses for the businesses and the businesses know that This is not an environment where excuses are tolerated. And so I think that can play out very, very strongly as it has. But beyond that, we've got a great portfolio of products. We've got a great group of customers that we really emphasize just servicing the hell out of them. And I think that's a great model. We've got great people. If anything, our turnover has reduced each of the last three years and a lot of our key roles around the company. And so A lot of these things are coming together in a real positive way, and I'm very, very happy with the quality of the people we have here, the portfolio. After all that painful restructuring, this is a great portfolio, and we've got a lot of really new products that are coming out. We've made a lot of good capital investments. Steve mentioned what our capital spend will be for the year. So I think that's been largely the formula for us.
spk01: Sounds good. And then just on the natural colors and flavors, obviously that's been a trend in terms of consumers' preference for more natural ingredients and colors. But as you referenced higher input costs, has that resulted in a slowdown from synthetic to natural?
spk02: No. Interestingly enough, we've observed the opposite. there are a lot of great brands out there that are going to be aggressive even in these types of markets. They're going to launch new products. They're going to launch exciting products. And we are right there with them supporting their needs. So, no, the natural color sales continue to be quite strong, literally in almost every one of our regions. And so we have not seen a slowdown. By our estimates, what we read, 78% to 80% of new product launches around the world continue to be using natural colors as the type of color. And the other balance is synthetic and in Europe, coloring food. So it's a really, really good dynamic. And we see continued underlining strong trends and growth coming out of natural colors. You know, natural flavors... Most of the markets we deal in have substantially already converted to that. I would tell you that, for example, in the U.S., 90 plus percent of our flavors are natural flavors. There are still some product lines out there utilizing synthetic, more of a synthetic flavor profile. So less to say about that one. But yeah, for the natural colors, still really, really good dynamics.
spk01: Okay, thanks. And then finally, I know you just announced the endemic acquisition. Just curious, in terms of your M&A appetite, given the rising interest rate environment and your willingness to lever up the balance sheet.
spk02: Well, I guess as a rule of thumb, we've always said in the M&A side of things, if you want it bad, you're going to get it bad. And we've been very, very disciplined such that we don't use that mindset. We've walked away from a lot of potential opportunities that we felt were not valued consistent with our valuations. We're very, very excited about endemics. I think this fits in exactly with the type of company we want. They have, in their case, they have a very nice position from a supply chain standpoint. but we could find a win-win with that organization. I think it's a great cultural fit to Sensient, and it is what we've always described as kind of this bolt-on acquisition. We're not going to fret over integration activities and moving around plants and screwing up a bunch of stuff. We buy it, we invest in it, and we continue to make use and learn from a lot of their techniques and leverage their products around throughout the rest of the Sensient network. So, hey, we're always looking at things to acquire, but you got to have a win-win. And a win-win means they get a fair price and we get a fair price. So if I can continue to find those scenarios, sounds great. We've got the balance sheet to accommodate that. Yeah, you're right. Interest rates, those certainly factor into the denominator of these valuations. But you can still, at the type of scale that we're looking at, maybe that's less of a consideration than if I was going to buy some massive entity out there somewhere.
spk01: Okay, that's very helpful. Thanks again for taking the question. Okay, thanks, Mitra. Yep.
spk06: Again, if you would like to ask a question, please press star then 1. The next question is from David Green with Boldhaven. Please go ahead. Hi, Paul. Hi, Steve. Hi, David.
spk07: A lot of my questions have been answered, so a few, I hope you don't mind some more sort of detailed ones, more specific. Just actually on the F&E side, how much of a headwind to top line were those onion constraints and shortages in Q3? And then two sort of final questions. One was just on the SG&A, which ticked up a bit this quarter. whether there was anything there or if that does normalize. And then the final question was on the corporate and other, which is obviously primarily the stock-based comp, which obviously has been increasing this year, but you've obviously changed the structure now. So has this now peaked and should we expect the absolute level to be, I guess, quite a bit lower going forward?
spk02: Okay, I'll take the S&I one, and then Steve can't wait to answer questions two and three there, which are to some degree related. On the S&I front, yeah, as I said in the prepared comments, I got that wrong in terms of the timing of when we'd be in a better situation there. So, okay, I was off maybe a quarter or so. So I think that moving forward, We certainly confirm our growth expectations for flavors for the year as an overall entity. I think as I look at 2023, I think the S&I piece is going to have a really good year. You remember last year we had, or I should say Q4 2021, I talked about how we had a real selling frenzy, and we had sold and really kind of oversold and outsold our position. Such that as we got into Q1 and Q2 of 2022, we had a real deficit of product. So we're not going to have that problem as we get into 2023. So I think you'll see some nice uplift coming out of S&I, really right out of the gate as you look at 2023. So that'll be a nice tailwind for us. moving forward. And then, of course, as that being the one-third of the flavors and extracts group, I continue to feel quite good about the two-thirds of the flavors and extracts group related to flavors, where, again, we've had very nice growth throughout the year on the ingredients part of that portfolio, very nice growth rate this year. So I feel quite good about our chances there, and I think we will only I think we'll be in a much better position to only be talking about the positive attributes of S&I as we begin 2023. But with that, let me let Steve talk to you about the SG&A and the corporate one.
spk00: Yeah, so I'll do the last one first, David. On the corporate expense, so on an adjusted basis, we're up about $2.6 million in the quarter. I can tell you about 60% of that was stock-based comps. And I know we've been talking about this for a while, but we have such a strong performance-based program that a few years ago, you know, we essentially weren't earning equity awards, and that zeroed out. And so it really takes three years to sort of build that back, and we're in that third year. So I think you're still seeing a little bit of step up this year. But then as we get to next year, you should see more normal increases. And then when you look at the – the second question was on overall SG&A. Is that correct?
spk07: Yes, that's right.
spk00: Yeah, so there again, you know, the increase, probably half of that was the stock I just mentioned and other incentives. So, you know – If you go back to last year, Color's performance sort of improved over the course of the year, and they're having an excellent year this year. So you're seeing higher incentive accruals in parts of our business related to performance. Then the other half is really going to be travel, which has stepped up, and then higher salary and wages would make up the remainder of the increase.
spk07: Great. Thanks very much.
spk06: Okay. Thanks, David. there are no further questions at this time. I will turn the conference back to the company for any closing remarks.
spk00: Okay. Thank you for your time this morning. Just maybe a closing comment as you're updating your models after the call. Just keep in mind we mentioned a couple of headwinds, and I'll just give you the specifics as to how those may impact Q4. So we talked about interest expense in Q4. If you look at year-over-year EPS impact, it's probably going to be approximately a $0.04 headwind. And then foreign exchange, probably about an $0.08 headwind in Q4 versus prior year. So I think everybody's aware that interest rates are increasing. We have a modest increase in our debt level. So you saw about a $600,000 sequential increase in Q3. we'd expect about approximately a million-dollar sequential increase in interest going into Q4. And then on FX, you know, I mentioned that that was a six-cent headwind in Q3, and it'll be a little worse. It'll be eight cents by our forecast in Q4. So, again, thank you for your time this morning, and that will conclude our call.
spk06: And thank you, sir. The conference has now concluded. You may now disconnect your line.
Disclaimer